We are live on
!
Find out more
AAM
Augustine Asset Management Portfolio holdings
AUM
$464M
1-Year Est. Return
16.89%
This Fund
S&P 500
This Quarter
Est. Return
+19.13%
1 Year Est. Return
+16.89%
3 Year Est. Return
+315.55%
5 Year Est. Return
+409.69%
10 Year Est. Return
+1,002.61%
AUM
$494M
AUM Growth
+$49.8M
(+11%)
Cap. Flow
-$17.2M
Cap. Flow
% of AUM
-3.47%
Top 10 Holdings %
Top 10 Hldgs %
65.12%
Holding
123
New
11
Increased
13
Reduced
72
Closed
2
Avg Time Held
16.8
quarters
Top 10 Avg Time Held
19.5
quarters
Top 20 Avg Time Held
19.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$4.21M |
| 2 |
United Therapeutics
UTHR
|
+$2.21M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.64M |
| 4 |
American Express
AXP
|
+$639K |
| 5 |
Shell
SHEL
|
+$503K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$8.67M |
| 2 |
Applovin
APP
|
+$6.46M |
| 3 |
TSMC
TSM
|
+$4.9M |
| 4 |
Dr. Reddy's Laboratories
RDY
|
+$3.18M |
| 5 |
Nike
NKE
|
+$1.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 28.17% |
| 2 | Technology | 22.41% |
| 3 | Energy | 13.56% |
| 4 | Financials | 11.52% |
| 5 | Healthcare | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Applovin
APP
$90.8B
| $131M | 26.46% |
253,670
-13,381
| -5% | -$6.46M |
2022 Q3
15 quarters
|
|
2
Kodiak Gas Services
KGS
$5.19B
| $45.8M | 9.27% |
609,394
| – | – |
2024 Q2
8 quarters
|
|
3
Apple
AAPL
$5.01T
| $40M | 8.1% |
138,177
-552
| -0.4% | -$158K |
2017 Q1
37 quarters
|
|
|
4
TSMC
TSM
$2.3T
| $26.6M | 5.39% |
55,694
-12,081
| -18% | -$4.9M |
2014 Q3
47 quarters
|
|
5
Microsoft
MSFT
$4.06T
| $21.3M | 4.32% |
57,172
-448
| -0.8% | -$181K |
2013 Q2
52 quarters
|
|
6
Goldman Sachs Physical Gold ETF Shares
AAAU
$2.52B
| $15M | 3.05% |
380,296
-843
| -0.2% | -$37.5K |
2022 Q3
15 quarters
|
|
7
JPMorgan Chase
JPM
$891B
| $11.3M | 2.3% |
34,648
-240
| -0.7% | -$74.5K |
2013 Q2
52 quarters
|
|
8
ICICI Bank
IBN
$102B
| $10.7M | 2.17% |
368,519
-2,744
| -0.7% | -$74.2K |
2017 Q1
37 quarters
|
|
9
iShares Silver Trust
SLV
$28.8B
| $10.7M | 2.17% |
199,997
-774
| -0.4% | -$51.3K |
2020 Q3
23 quarters
|
|
10
ASML
ASML
$652B
| $9.45M | 1.91% |
4,752
-42
| -0.9% | -$66.9K |
2024 Q4
6 quarters
|
|
11
Merck
MRK
$353B
| $9.34M | 1.89% |
72,655
-560
| -0.8% | -$65.5K |
2013 Q2
52 quarters
|
|
|
12
Shell
SHEL
$292B
| $8.54M | 1.73% |
110,138
+5,825
| +6% | +$503K |
2022 Q1
17 quarters
|
|
13
Mizuho Financial
MFG
$128B
| $7.83M | 1.59% |
817,384
-5,789
| -0.7% | -$52K |
2023 Q4
10 quarters
|
|
14
TotalEnergies
TTE
$196B
| $7.22M | 1.46% |
92,789
+1,109
| +1% | +$98.1K |
2019 Q4
26 quarters
|
|
15
Mitsubishi UFJ Financial
MUFG
$252B
| $6.89M | 1.4% |
346,501
-3,959
| -1% | -$74.6K |
2021 Q2
20 quarters
|
|
16
Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 1.2 shares of Common Stock)
SMFG
$158B
| $6.19M | 1.25% |
262,517
-1,721
| -0.7% | -$38.2K |
2023 Q4
10 quarters
|
|
17
Gilead Sciences
GILD
$184B
| $6.13M | 1.24% |
48,484
-449
| -0.9% | -$59.2K |
2017 Q3
35 quarters
|
|
|
18
Micron Technology
MU
$1.06T
| $5.98M | 1.21% |
5,185
-11,567
| -69% | -$8.67M |
2021 Q4
18 quarters
|
|
|
19
United Therapeutics
UTHR
$23.5B
| $5.36M | 1.09% |
9,892
+3,919
| +66% | +$2.21M |
2025 Q2
4 quarters
|
|
20
BHP
BHP
$215B
| $5.27M | 1.07% |
63,294
-286
| -0.4% | -$23.7K |
2025 Q4
2 quarters
|
|
21
Ecolab
ECL
$80.1B
| $5.15M | 1.04% |
18,481
-125
| -0.7% | -$32.9K |
2013 Q2
52 quarters
|
|
22
Freeport-McMoran
FCX
$103B
| $5.02M | 1.02% |
79,829
-404
| -0.5% | -$26K |
2026 Q1
1 quarter
|
|
|
23
Halozyme
HALO
$12.4B
| $4.83M | 0.98% |
+61,707
| New | +$4.21M |
2026 Q2
0 quarters
|
|
|
24
Regeneron Pharmaceuticals
REGN
$77.5B
| $4.29M | 0.87% |
6,884
+2,405
| +54% | +$1.64M |
2020 Q1
25 quarters
|
|
25
Berkshire Hathaway Class B
BRK.B
$1.12T
| $3.7M | 0.75% |
7,401
-2
| -0% | -$962 |
2018 Q1
33 quarters
|
|
Similar funds
NF
HFBOT
P
CWA
MIG
SW
SCM
UAM
Augustine Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, Augustine Asset Management held 123 positions worth $494M, up 11% from $444M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Augustine Asset Management withdrew a net $17.2M in Q2 2026, closing 2 positions and reducing 72 holdings. Its most notable exit was Nike, an estimated $1.65M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 28% of assets, up from 26% a quarter earlier, followed by Technology and Energy.
Against the trend, Augustine Asset Management opened a new position in Halozyme worth $4.83M.
- Augustine Asset Management's largest Q2 2026 buy was Halozyme: 61,707 shares worth $4.83M.
- Augustine Asset Management added most to United Therapeutics in Q2 2026, an estimated $2.21M increase.
- Augustine Asset Management's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $8.67M.
- Augustine Asset Management fully exited Nike in Q2 2026, selling an estimated $1.65M.
- Augustine Asset Management's ten largest holdings make up 65% of its $494M portfolio in Q2 2026.
- Augustine Asset Management opened 11 new positions and closed 2 in Q2 2026.
- Augustine Asset Management's portfolio value rose 11% quarter-over-quarter to $494M.
Based on Augustine Asset Management's 13F filing for Q2 2026, filed 13 Jul 2026.